Cargando…

Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm

BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yong, He, Shun, Zhang, Yueming, Dou, Lizhou, Liu, Xiao, Yu, Xinying, Lu, Ning, Xue, Liyan, Wang, Guiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944311/
https://www.ncbi.nlm.nih.gov/pubmed/33708949
http://dx.doi.org/10.21037/atm-20-4265
_version_ 1783662663263322112
author Liu, Yong
He, Shun
Zhang, Yueming
Dou, Lizhou
Liu, Xiao
Yu, Xinying
Lu, Ning
Xue, Liyan
Wang, Guiqi
author_facet Liu, Yong
He, Shun
Zhang, Yueming
Dou, Lizhou
Liu, Xiao
Yu, Xinying
Lu, Ning
Xue, Liyan
Wang, Guiqi
author_sort Liu, Yong
collection PubMed
description BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total of 130 patients with EGJ neoplasm underwent endoscopic resection, including 52 patients with EMR and 78 patients with ESD. Cap-assisted EMR (EMRC) was performed with typical sequences. Larger lesions required removal in multiple pieces (i.e., piecemeal EMR). The ESD procedures were included that marking the periphery of the lesion, submucosa injected, circumferentially cutting and submucosal dissection. Resection time, adverse events, en bloc resection rate, R0 resection rate and recurrence rate were compared between the two groups. RESULTS: There were no significant differences in demographic characteristics or histopathological features between the two groups. Resection time was longer in the ESD group than in the EMR group (64.4±33.9 vs. 22.1±8.0 minutes; P<0.01). Adverse events were more common in the ESD group than in the EMR group (16.7% vs. 3.8%; P=0.03), including bleeding (7.7% vs. 3.8%), perforation (5.1% vs. 0%) and stenosis (5.1% vs. 0%). The en bloc resection rate and R0 resection rate were much higher in the ESD group than in the EMR group (98.7% and 92.3% vs. 23.1% and 23.1%, respectively; P<0.01). The 5-year overall survival rate and disease-free survival rate were 100% vs. 92.0% and 100% vs. 90.1% between the ESD and EMR groups, respectively (P=0.01 and P=0.01). The 5-year cancer-specific survival rate was 100% vs. 96.0% between the ESD and EMR groups (P=0.08). The recurrence rate was lower in the ESD group than in the EMR group (0% vs. 9.6%; P=0.01). CONCLUSIONS: ESD is an acceptable first-line endoscopic treatment for type II EGJ neoplasm, however, it is time-consuming and has a higher rate of adverse events. Furthermore, EMR is a safe and alternative technique, particularly when EMR could achieve en bloc resection.
format Online
Article
Text
id pubmed-7944311
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-79443112021-03-10 Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm Liu, Yong He, Shun Zhang, Yueming Dou, Lizhou Liu, Xiao Yu, Xinying Lu, Ning Xue, Liyan Wang, Guiqi Ann Transl Med Original Article BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total of 130 patients with EGJ neoplasm underwent endoscopic resection, including 52 patients with EMR and 78 patients with ESD. Cap-assisted EMR (EMRC) was performed with typical sequences. Larger lesions required removal in multiple pieces (i.e., piecemeal EMR). The ESD procedures were included that marking the periphery of the lesion, submucosa injected, circumferentially cutting and submucosal dissection. Resection time, adverse events, en bloc resection rate, R0 resection rate and recurrence rate were compared between the two groups. RESULTS: There were no significant differences in demographic characteristics or histopathological features between the two groups. Resection time was longer in the ESD group than in the EMR group (64.4±33.9 vs. 22.1±8.0 minutes; P<0.01). Adverse events were more common in the ESD group than in the EMR group (16.7% vs. 3.8%; P=0.03), including bleeding (7.7% vs. 3.8%), perforation (5.1% vs. 0%) and stenosis (5.1% vs. 0%). The en bloc resection rate and R0 resection rate were much higher in the ESD group than in the EMR group (98.7% and 92.3% vs. 23.1% and 23.1%, respectively; P<0.01). The 5-year overall survival rate and disease-free survival rate were 100% vs. 92.0% and 100% vs. 90.1% between the ESD and EMR groups, respectively (P=0.01 and P=0.01). The 5-year cancer-specific survival rate was 100% vs. 96.0% between the ESD and EMR groups (P=0.08). The recurrence rate was lower in the ESD group than in the EMR group (0% vs. 9.6%; P=0.01). CONCLUSIONS: ESD is an acceptable first-line endoscopic treatment for type II EGJ neoplasm, however, it is time-consuming and has a higher rate of adverse events. Furthermore, EMR is a safe and alternative technique, particularly when EMR could achieve en bloc resection. AME Publishing Company 2021-02 /pmc/articles/PMC7944311/ /pubmed/33708949 http://dx.doi.org/10.21037/atm-20-4265 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Liu, Yong
He, Shun
Zhang, Yueming
Dou, Lizhou
Liu, Xiao
Yu, Xinying
Lu, Ning
Xue, Liyan
Wang, Guiqi
Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title_full Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title_fullStr Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title_full_unstemmed Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title_short Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
title_sort comparing long-term outcomes between endoscopic submucosal dissection (esd) and endoscopic mucosal resection (emr) for type ii esophagogastric junction neoplasm
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944311/
https://www.ncbi.nlm.nih.gov/pubmed/33708949
http://dx.doi.org/10.21037/atm-20-4265
work_keys_str_mv AT liuyong comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT heshun comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT zhangyueming comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT doulizhou comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT liuxiao comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT yuxinying comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT luning comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT xueliyan comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm
AT wangguiqi comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm